{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:16:28Z","timestamp":1740122188848,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32-DK007533-35","K08-DK119475"],"award-info":[{"award-number":["T32-DK007533-35","K08-DK119475"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007827","name":"American College of Gastroenterology","doi-asserted-by":"publisher","award":["ACG-JR-010-2020"],"award-info":[{"award-number":["ACG-JR-010-2020"]}],"id":[{"id":"10.13039\/100007827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10620-021-07062-7","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T02:04:00Z","timestamp":1622253840000},"page":"2310-2319","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Endoscopy Is Not Associated with Infectious Adverse Events After Hematopoietic Cell Transplantation: A Retrospective Cohort Study"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0396-9306","authenticated-orcid":false,"given":"Abraham","family":"Segura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul S.","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghana","family":"Golla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James N.","family":"Gerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadim","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravy K.","family":"Vajravelu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,29]]},"reference":[{"key":"7062_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00277-003-0756-4","volume":"83","author":"A Schulenburg","year":"2004","unstructured":"Schulenburg A, Turetschek K, Wrba F et al. Early and late gastrointestinal complications after myeloablative and nonmyeloablative allogeneic stem cell transplantation. Ann Hematol 2004;83:101\u2013106.","journal-title":"Ann Hematol"},{"key":"7062_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/sj.bmt.1703130","volume":"28","author":"G Fallows","year":"2001","unstructured":"Fallows G, Rubinger M, Bernstein CN. Does gastroenterology consultation change management of patients receiving hematopoietic stem cell transplantation? Bone Marrow Transplant 2001;28:289\u2013294.","journal-title":"Bone Marrow Transplant"},{"key":"7062_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/0002-9343(90)90289-P","volume":"89","author":"JA Bianco","year":"1990","unstructured":"Bianco JA, Pepe MS, Higano C et al. Prevalence of clinically relevant bacteremia after upper gastrointestinal endoscopy in bone marrow transplant recipients. Am J Med 1990;89:134\u2013136.","journal-title":"Am J Med"},{"key":"7062_CR4","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.gie.2018.12.004","volume":"89","author":"H Abu-Sbeih","year":"2019","unstructured":"Abu-Sbeih H, Ali FS, Coronel E et al. Safety of endoscopy in cancer patients with thrombocytopenia and neutropenia. Gastrointestinal Endosc 2019;89:937-949.e932.","journal-title":"Gastrointestinal Endosc"},{"key":"7062_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.idc.2010.01.010","volume":"24","author":"JR Wingard","year":"2010","unstructured":"Wingard JR, Hsu J, Hiemenz JW. Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology. Infect Dis Clin North Am 2010;24:257\u2013272.","journal-title":"Infect Dis Clin North Am"},{"key":"7062_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/CCM.0000000000000714","volume":"43","author":"G Kumar","year":"2015","unstructured":"Kumar G, Ahmad S, Taneja A et al. Severe sepsis in hematopoietic stem cell transplant recipients. Crit Care Med 2015;43:411\u2013421.","journal-title":"Crit Care Med"},{"key":"7062_CR7","doi-asserted-by":"crossref","unstructured":"Allison MC, Sandoe JAT, Tighe R, et al. Antibiotic prophylaxis in gastrointestinal endoscopy. 2009;869\u2013880.","DOI":"10.1136\/gut.2007.136580"},{"key":"7062_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.gie.2014.08.008","volume":"81","author":"MA Khashab","year":"2015","unstructured":"Khashab MA, Chithadi KV, Acosta RD et al. Antibiotic prophylaxis for GI endoscopy. Gastrointestinal Endosc 2015;81:81\u201389.","journal-title":"Gastrointestinal Endosc"},{"key":"7062_CR9","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.bbmt.2017.05.035","volume":"23","author":"A D'Souza","year":"2017","unstructured":"D\u2019Souza A, Lee S, Zhu X, Pasquini M. Current use and trends in hematopoietic cell transplantation in the United States. Biol Blood Marrow Transplant 2017;23:1417\u20131421.","journal-title":"Biol Blood Marrow Transplant"},{"key":"7062_CR10","doi-asserted-by":"publisher","first-page":"AB84","DOI":"10.1016\/j.gie.2020.03.628","volume":"91","author":"M Golla","year":"2020","unstructured":"Golla M, Segura A, Gerson JN, Mahmud N, Vajravelu RK. 967 National trends of gastrointestinal endoscopy after hematopoietic cell transplantation in The United States, 2012\u20132016. Gastrointestinal Endosc 2020;91:AB84\u2013AB84.","journal-title":"Gastrointestinal Endosc"},{"key":"7062_CR11","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1001\/jama.2017.13836","volume":"318","author":"C Rhee","year":"2017","unstructured":"Rhee C, Dantes R, Epstein L et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009\u20132014. JAMA J Am Med Assoc 2017;318:1241\u20131249.","journal-title":"JAMA J Am Med Assoc"},{"key":"7062_CR12","first-page":"801","volume-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour C et al. The third international consensus definitions for sepsis and septic shock (sepsis-3), New York: American Medical Association; 2016; 801\u2013810."},{"key":"7062_CR13","doi-asserted-by":"crossref","unstructured":"Calderwood AH, Day LW, Raman Muthusamy V, et al. Communication from the ASGE quality assurance in endoscopy committee guideline infection control during GI endoscopy prepared by: ASGE Quality Assurance in Endoscopy Committee. 2017.","DOI":"10.1016\/j.gie.2017.12.009"},{"key":"7062_CR14","doi-asserted-by":"crossref","unstructured":"Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. City; Elsevier: pp. 1644\u20131655.","DOI":"10.1378\/chest.101.6.1644"},{"key":"7062_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13017-018-0165-6","volume-title":"Raising concerns about the Sepsis-3 definitions","author":"M Sartelli","year":"2018","unstructured":"Sartelli M, Kluger Y, Ansaloni L et al. Raising concerns about the Sepsis-3 definitions. New York: BioMed Central Ltd; 2018."},{"key":"7062_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373\u2013383.","journal-title":"J Chronic Dis"},{"key":"7062_CR17","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613\u2013619.","journal-title":"J Clin Epidemiol"},{"key":"7062_CR18","first-page":"174","volume-title":"How to approach neutropenia","author":"LA Boxer","year":"2012","unstructured":"Boxer LA. How to approach neutropenia, New York: American Society of Hematology; 2012; 174\u2013182."},{"key":"7062_CR19","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/MIB.0000000000001095","volume":"23","author":"H Yang","year":"2017","unstructured":"Yang H, Zhou W, Lv H et al. The association between CMV viremia or endoscopic features and histopathological characteristics of CMV colitis in patients with underlying ulcerative colitis. Inflamm Bowel Dis 2017;23:814\u2013821.","journal-title":"Inflamm Bowel Dis"},{"key":"7062_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41\u201355.","journal-title":"Biometrika"},{"key":"7062_CR21","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/j.1572-0241.2007.01639.x","volume":"103","author":"WA Ross","year":"2008","unstructured":"Ross WA, Ghosh S, Dekovich AA et al. Endoscopic biopsy diagnosis of acute gastrointestinal graft-versus-host disease: rectosigmoid biopsies are more sensitive than upper gastrointestinal biopsies. Am J Gastroenterol 2008;103:982\u2013989.","journal-title":"Am J Gastroenterol"},{"key":"7062_CR22","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.bbmt.2009.03.009","volume":"15","author":"F Carnevale-Schianca","year":"2009","unstructured":"Carnevale-Schianca F, Leisenring W, Martin PJ et al. Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study. Biol Blood Marrow Transplant 2009;15:749\u2013756.","journal-title":"Biol Blood Marrow Transplant"},{"key":"7062_CR23","first-page":"711","volume-title":"Acute graft-versus-host disease of the gut: considerations for the gastroenterologist","author":"S Naymagon","year":"2017","unstructured":"Naymagon S, Naymagon L, Wong SY et al. Acute graft-versus-host disease of the gut: considerations for the gastroenterologist, New York: Nature Publishing Group; 2017; 711\u2013726."},{"key":"7062_CR24","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/s41409-019-0748-1","volume":"55","author":"NS Majhail","year":"2020","unstructured":"Majhail NS, Mau LW, Chitphakdithai P et al. Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adults. Bone Marrow Transplant 2020;55:906\u2013917.","journal-title":"Bone Marrow Transplant"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07062-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-021-07062-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07062-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T16:10:44Z","timestamp":1654359044000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-021-07062-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,29]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["7062"],"URL":"https:\/\/doi.org\/10.1007\/s10620-021-07062-7","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2021,5,29]]},"assertion":[{"value":"3 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Abraham Segura: None declared. Rahul S. Dalal: None declared. Meghana Golla: None declared. James N. Gerson: Served as an advisory board member for AbbVie, Genentech, and TG therapeutics. The scope of work for each of these was unrelated to this research. He has received research support from Loxo Oncology, also unrelated to this research. Nadim Mahmud: None declared. James D. Lewis: Served as a consultant to AbbVie, Arena Pharmaceuticals, Bristol-Myers Squibb, Bridge Biotherapeutics, Celgene, Gilead, Janssen, Johnson & Johnson Consumer Inc, Lilly, Merck, Nestle Health Science, Pfizer, Samsung Bioepis, Takeda, and UCB. The scope of work for each of these was unrelated to this research. He has received research funding from Nestle Health Science, Janssen and Takeda, also unrelated to this research. Ravy K. Vajravelu: None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}